Early Phase 1 Thrombocytopenia Clinical Trials

5 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–5 of 5 trials

Recruiting

Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more

Rushad Patell30 enrolled1 locationNCT06886516

Recruiting

Early Phase 1

Single Arm Romiplostim to Prevent CIT

Ewings SarcomaChemotherapy Induced Thrombocytopenia

Children's Hospital Medical Center, Cincinnati26 enrolled2 locationsNCT07048249

Recruiting

Early Phase 1

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6 enrolled2 locationsNCT06519565

Recruiting

Early Phase 1

Safety Study of CC312 in Autoimmune Disease Patients

Rheumatoid Arthritis (RA)Autoimmune Hemolytic AnemiaSystemic Lupus Erythematosus (SLE)+3 more

CytoCares Inc18 enrolled1 locationNCT06888960

Recruiting

Early Phase 1

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Thrombocytopenia Alloimmune

Changzhou No.2 People's Hospital9 enrolled1 locationNCT06337474